Glenn J. Bubley
Beth Israel Deaconess Medical Center · 443 works · 47,102 citations · h-index 79
Top works
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group
- The idiopathic hypereosinophilic syndrome
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
- The Molecular Taxonomy of Primary Prostate Cancer
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
- Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.
- Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer
- Biology of Prostate-Specific Antigen
- Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
- Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
- Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy
- Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.
- Pathogenic Germline Variants in 10,389 Adult Cancers